NGM

NGM Biopharmaceuticals, Inc. Common Stock
NGM

Overview Fund Activity
Delisted

NGM was delisted on the 4th of April, 2024.

Back to rankings

125 hedge funds and large institutions have $246M invested in NGM Biopharmaceuticals, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 62 increasing their positions, 22 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
125
Holders Change
-3
Holders Change %
-2.34%
% of All Funds
2.02%
Holding in Top 10
2
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-60%
% of All Funds
0.03%
New
24
Increased
62
Reduced
22
Closed
25
Calls
$1.33M
Puts
$3K
Net Calls
+$1.32M
Net Calls Change
-$5.32M

Top Buyers

1
EC
1
EcoR1 Capital
California
$32.3M
2
Jacobs Levy Equity Management
2
Jacobs Levy Equity Management
New Jersey
$3.38M
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$22.5M
4
Acadian Asset Management
4
Acadian Asset Management
Massachusetts
$2.91M
5
Millennium Management
5
Millennium Management
New York
$2.3M

Top Sellers

1
APM
1
Avidity Partners Management
Texas
$0
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$233K
3
FLAM
3
First Light Asset Management
Minnesota
$0
4
LGM
4
Logos Global Management
California
$0
5
Point72 Asset Management
5
Point72 Asset Management
Connecticut
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Walleye Capital
26
Walleye Capital
New York
$1.13M +$1.05M +209,648 +1,429%
PAM
27
Panagora Asset Management
Massachusetts
$783K +$59.1K +11,778 +8%
Connor, Clark & Lunn Investment Management (CC&L)
28
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$775K +$219K +43,711 +39%
State of Wisconsin Investment Board
29
State of Wisconsin Investment Board
Wisconsin
$769K +$614K +122,235 +395%
CSS
30
Cubist Systematic Strategies
Connecticut
$698K +$321K +64,018 +85%
Man Group
31
Man Group
United Kingdom
$690K +$507K +101,044 +277%
Bank of New York Mellon
32
Bank of New York Mellon
New York
$670K -$86.4K -17,214 -11%
GCP
33
GSA Capital Partners
United Kingdom
$649K +$593K +118,220 +1,069%
D.E. Shaw & Co
34
D.E. Shaw & Co
New York
$617K -$81.8K -16,301 -12%
Axa
35
Axa
France
$570K -$1.47M -292,083 -72%
GCM
36
Graham Capital Management
Connecticut
$566K +$566K +112,777 New
ECM
37
ExodusPoint Capital Management
New York
$538K +$274K +54,542 +104%
PP
38
PDT Partners
New York
$524K +$352K +70,116 +205%
Squarepoint
39
Squarepoint
New York
$496K +$366K +72,853 +281%
PVI
40
Pura Vida Investments
New York
$417K -$264K -52,542 -39%
AQR Capital Management
41
AQR Capital Management
Connecticut
$384K +$384K +76,477 New
AG
42
Algert Global
California
$371K -$19.8K -3,950 -5%
Barclays
43
Barclays
United Kingdom
$350K +$130K +26,009 +59%
PL
44
Parkwood LLC
Ohio
$343K +$121K +24,000 +54%
Swiss National Bank
45
Swiss National Bank
Switzerland
$330K – – –
OQS
46
Occudo Quantitative Strategies
Florida
$324K +$324K +64,493 New
AllianceBernstein
47
AllianceBernstein
Tennessee
$299K +$105K +20,900 +54%
HWAM
48
Hennion & Walsh Asset Management
New Jersey
$296K -$585K -116,314 -66%
AA
49
ALPS Advisors
Colorado
$279K +$279K +55,520 New
RhumbLine Advisers
50
RhumbLine Advisers
Massachusetts
$275K +$2.72K +541 +1%
1
2
3 4 5